Contribution of the hepatic lipase gene to the atherogenic lipoprotein phenotype in familial combined hyperlipidemia

被引:0
|
作者
Allayee, H
Dominguez, KM
Aouizerat, BE
Krauss, RM
Rotter, JI
Lu, JY
Cantor, RM
de Bruin, TWA
Lusis, AJ [1 ]
机构
[1] Univ Calif Los Angeles, Dept Microbiol & Mol Genet, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA
[4] Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90095 USA
[5] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA
[6] Univ Calif Berkeley, Div Life Sci, Lawrence Berkeley Natl Lab, Berkeley, CA USA
[7] Steven Spielberg Pediat Res Ctr, Div Med Genet, Los Angeles, CA USA
[8] Acad Hosp Maastricht, Dept Med, NL-6202 HX Maastricht, Netherlands
[9] Acad Hosp Maastricht, Dept Endocrinol, NL-6202 HX Maastricht, Netherlands
关键词
familial combined hyperlipidemia; atherogenic lipoprotein phenotype; hepatic lipase; genetic linkage analysis;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Familial combined hyperlipidemia (FCH) is a common genetic lipid disorder with a frequency of 1-2% in the population. In addition to the hypercholesterolemia and/or hypertriglyceridemia that affected individuals exhibit, small, dense LDL particles and decreased HDL, cholesterol levels are traits frequently associated with FCH, Recently, we reported that families with FCH and families enriched for coronary artery disease (CAD) share genetic determinants for the atherogenic lipoprotein phenotype (ALP), a profile presenting with small, dense LDL particles, decreased HDL-cholesterol levels, and increased triglyceride levels. Other studies in normolipidemic populations have shown that the hepatic lipase (HL) gene is linked to HDL-cholesterol levels and that a polymorphism within the HL promoter (-514C-->T) is associated with increased HDL-cholesterol levels as well as larger, more buoyant LDL particles. In the present study, we tested whether the HL gene locus also contributes to ALP in a series of Dutch FCH families using nonparametric sibpair linkage analysis and association analysis. Evidence for linkage of LDL particle size (P < 0.019), HDL-cholesterol (P < 0.003), and triglyceride levels (P < 0.026) to the HL gene locus was observed. A genome scan in a subset of these families exhibited evidence for linkage of PPD (LOD = 2.2) and HDL-cholesterol levels (LOD = 1.2) to the HL gene locus as well. The -514C-->T promoter polymorphism was significantly associated (P < 0.0001) with higher HDL-cholesterol levels in the unrelated males of this population, but not in unrelated females. No association was observed between the polymorphism and LDL particle size or triglyceride levels. jlr Our results provide support that ALP is a multigenic trait and suggest that the relationship between small, dense LDL particles, HDL cholesterol, and triglyceride levels in FCH families is due, in part, to common genetic factors.
引用
收藏
页码:245 / 252
页数:8
相关论文
共 50 条
  • [1] Lipoprotein lipase in familial combined hyperlipidemia.
    Deeb, SS
    Brunzell, JD
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 1998, 46 (01) : 117A - 117A
  • [2] Lipoprotein lipase gene analysis in Japanese patients with familial combined hyperlipidemia
    Nozue, T
    Todo, Y
    Nohara, A
    Inazu, A
    Kajinami, K
    Koizumi, J
    Mabuchi, H
    [J]. ATHEROSCLEROSIS, 1999, 144 : 18 - 18
  • [3] FAMILIAL COMBINED HYPERLIPIDEMIA AND ABNORMAL LIPOPROTEIN-LIPASE
    BABIRAK, SP
    BROWN, BG
    BRUNZELL, JD
    [J]. ARTERIOSCLEROSIS AND THROMBOSIS, 1992, 12 (10): : 1176 - 1183
  • [4] Lipoprotein phenotype and insulin resistance in familial combined hyperlipidemia
    Ascaso, JF
    Real, JT
    Merchante, A
    Rodrigo, A
    Carmena, R
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2000, 49 (12): : 1627 - 1631
  • [5] POINT MUTATIONS IN THE HEPATIC TRIGLYCERIDE LIPASE (HTGL) GENE IN FAMILIAL COMBINED HYPERLIPIDEMIA (FCHL)
    GEHRISCH, S
    TESCHE, R
    KOSTKA, H
    JULIUS, U
    JAROSS, W
    [J]. CIRCULATION, 1995, 92 (08) : 2352 - 2352
  • [6] Mutations in the hepatic lipase, lipoprotein lipase and apo E but not the insulin receptor are susceptibility alleles modifying familial combined hyperlipidemia
    Gehrisch, S
    Kostka, H
    Julius, U
    Hanefeld, M
    Schroeder, HE
    Jaross, W
    [J]. ATHEROSCLEROSIS, 1998, 138 : S6 - S6
  • [7] Lipase gene mutations and familial combined hyperlipidemia phenotypes
    Stalenhoef, AFH
    Bredie, SJH
    Kastelein, JJP
    Frants, RR
    Hoffer, MJV
    [J]. ATHEROSCLEROSIS, 1998, 138 : S5 - S5
  • [8] Point mutations in the genes of Lipoprotein lipase, hepatic lipase, and insulin receptor as possible susceptibility alleles in familial combined hyperlipidemia
    Jaross, W
    Gehrisch, S
    Julius, U
    Kostka, H
    Hanefeld, HM
    [J]. ATHEROSCLEROSIS, 1997, 134 (1-2) : 25 - 26
  • [9] MUTATIONS IN THE LIPOPROTEIN-LIPASE GENE IN FAMILIAL COMBINED HYPERLIPIDEMIA AND CORONARY-ARTERY DISEASE
    DEEB, SS
    YANG, WS
    NEVIN, D
    IWASAKI, L
    PENG, R
    BROWN, BG
    BRUNZELL, JD
    [J]. CIRCULATION, 1995, 92 (08) : 2351 - 2351
  • [10] DNA polymorphisms of lipoprotein lipase gene and apolipoprotein E in Hungarian patients with familial combined hyperlipidemia
    Reiber, I
    Szalai, C
    Gógl, A
    Romics, L
    Császár, A
    [J]. ATHEROSCLEROSIS, 1998, 138 : S14 - S14